Difference between revisions of "Ethics approval and consent to participate (from DOI: 10.1186/s13054-020-02882-x) (Q10759)"
Jump to navigation
Jump to search
(Created claim: Has Sectioning (P146): Section 3: COVID-19: Neuro-invasive potential of SARS-nCoV-2 as cause of delirium (from DOI: 10.1186/s13054-020-02882-x) (Q10753), #quickstatements; #temporary_batch_1593004563779) |
(Created claim: Has Sectioning (P146): Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) (Q10754), #quickstatements; #temporary_batch_1593004563779) |
||
Property / Has Sectioning | |||
+ | |||
Property / Has Sectioning: Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) / rank | |||
+ | Normal rank |
Revision as of 13:16, 24 June 2020
Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x
Language | Label | Description | Also known as |
---|---|---|---|
English |
Ethics approval and consent to participate (from DOI: 10.1186/s13054-020-02882-x)
|
Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x
|
Statements
0 references